Recent development in the design of antiviral agents.

about

Toward antiviral strategies that resist viral escape

P2860

Q33979280-61B09FE9-A02D-4597-8DA9-1BA2DCB3ACBE

P2860

Recent development in the design of antiviral agents.

Item

http://www.wikidata.org/entity/Q40943840

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Recent development in the design of antiviral agents.

@en

type

Item

label

Recent development in the design of antiviral agents.

@en

prefLabel

Recent development in the design of antiviral agents.

@en

P1476

Recent development in the design of antiviral agents.

@en

P2093

Cameron JM

http://www.w3.org/2001/XMLSchema#string

Saunders J

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets

(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides

Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)

Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

P304

497-531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MED.2610150604

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1995-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8558989

http://www.w3.org/2001/XMLSchema#string

Recent development in the design of antiviral agents.

about

P2860

P2860

Recent development in the design of antiviral agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698